Surgical management of subfoveal choroidal neovascular membranes in age-related macular degeneration by macular relocation: experiences of an early-stopped randomised clinical trial (MARAN Study)

A M Joussen;  ; D Wong; P Walter; B Kirchhof; J Dreyhaupt; C Bauer; J Munzinger; K Unnebrink; A Freiberger; M Seibert-Grafe; N Victor

doi:10.1038/eye.2009.107

Surgical management of subfoveal choroidal neovascular membranes in age-related macular degeneration by macular relocation: experiences of an early-stopped randomised clinical trial (MARAN Study)

Eye ◽

10.1038/eye.2009.107 ◽

2009 ◽

Vol 24 (2) ◽

pp. 284-289

Author(s):

A M Joussen ◽

◽

D Wong ◽

P Walter ◽

B Kirchhof ◽

...

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Surgical Management ◽

Randomised Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related

Get full-text (via PubEx)

Faculty Opinions recommendation of Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725825178.793530516 ◽

2017 ◽

Author(s):

Michael Singer

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Macular Degeneration ◽

Phase 1 ◽

Randomised Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related

Get full-text (via PubEx)

Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial

The Lancet ◽

10.1016/s0140-6736(15)00345-1 ◽

2015 ◽

Vol 386 (10011) ◽

pp. 2395-2403 ◽

Cited By ~ 86

Author(s):

Elizabeth P Rakoczy ◽

Chooi-May Lai ◽

Aaron L Magno ◽

Matthew E Wikstrom ◽

Martyn A French ◽

...

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Macular Degeneration ◽

Phase 1 ◽

Randomised Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related

Get full-text (via PubEx)

Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial

Graefe s Archive for Clinical and Experimental Ophthalmology ◽

10.1007/s00417-018-4163-x ◽

2018 ◽

Vol 257 (1) ◽

pp. 31-40 ◽

Cited By ~ 16

Author(s):

Geoffrey K. Broadhead ◽

John R. Grigg ◽

Peter McCluskey ◽

Thomas Hong ◽

Timothy E. Schlub ◽

...

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Randomised Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related

Get full-text (via PubEx)

Comment on ‘Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial’

Eye ◽

10.1038/eye.2011.18 ◽

2011 ◽

Vol 25 (6) ◽

pp. 820-820 ◽

Cited By ~ 2

Author(s):

T Fayers

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Randomised Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related

Get full-text (via PubEx)

The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study

BMC Ophthalmology ◽

10.1186/s12886-016-0207-3 ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 29

Author(s):

Jennifer J. Arnold ◽

Caroline M. Markey ◽

Nicol P. Kurstjens ◽

Robyn H. Guymer

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Treatment Outcomes ◽

Randomised Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related ◽

Phase Iv

Get full-text (via PubEx)

Response to comment on ‘Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial’

Eye ◽

10.1038/eye.2011.16 ◽

2011 ◽

Vol 25 (6) ◽

pp. 820-820 ◽

Cited By ~ 1

Author(s):

M L Subramanian

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Randomised Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related

Get full-text (via PubEx)

Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial

Eye ◽

10.1038/eye.2010.147 ◽

2010 ◽

Vol 24 (11) ◽

pp. 1708-1715 ◽

Cited By ~ 44

Author(s):

M L Subramanian ◽

G Abedi ◽

S Ness ◽

E Ahmed ◽

M Fenberg ◽

...

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Randomised Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related

Get full-text (via PubEx)

Faculty of 1000 evaluation for Improving function in age-related macular degeneration: a randomized clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718007696.793478654 ◽

2013 ◽

Author(s):

David Boyer

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Randomized Clinical Trial ◽

Age Related Macular Degeneration ◽

Age Related

Get full-text (via PubEx)

Faculty Opinions recommendation of Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718007638.793493580 ◽

2014 ◽

Author(s):

Michael Singer

Keyword(s):

Clinical Trial ◽

Fatty Acids ◽

Macular Degeneration ◽

Randomized Clinical Trial ◽

Age Related Macular Degeneration ◽

Eye Disease ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Age Related ◽

Disease Study

Get full-text (via PubEx)

Faculty Opinions recommendation of Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718007638.793477261 ◽

2013 ◽

Author(s):

Karl Csaky ◽

Debbie Chong

Keyword(s):

Clinical Trial ◽

Fatty Acids ◽

Macular Degeneration ◽

Randomized Clinical Trial ◽

Age Related Macular Degeneration ◽

Eye Disease ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Age Related ◽

Disease Study

Get full-text (via PubEx)